ACTRIMS 2024
MDA 2024
Roundtable Discussions
NeuroVoices
Mind Moments podcast
Gold Standard Centers
EEGTalk with Fabio Nascimento, MD, and Brandon Westover, MD, PhD
Brain Games

Conference Coverage

View All
Exon-Skipping Therapy Golodirsen Prolongs Ambulation in DMD, Long-Term Study Shows
Exon-Skipping Therapy Golodirsen Prolongs Ambulation in DMD, Long-Term Study Shows

March 4th 2024

David Lynch, MD, PhD, neurologist and director of the Friedreich's Ataxia Program at Children's Hospital of Philadelphia
Vatiquinone Treatment Shows Benefit Across End Points for Friedreich Ataxia in Phase 3 MOVE-FA Trial

March 4th 2024

Stephen Krieger, MD; Enrique Alvarez, MD, PhD
Redefining Relapse in Efficacy Measures for Multiple Sclerosis Treatments: Stephen Krieger, MD; Enrique Alvarez, MD, PhD

March 4th 2024

SRP-9001 Improves Duchenne Muscular Dystrophy Disease Trajectory Despite Failing to Meet Primary End Point in Phase 3 EMBARK Trial
SRP-9001 Improves Duchenne Muscular Dystrophy Disease Trajectory Despite Failing to Meet Primary End Point in Phase 3 EMBARK Trial

March 4th 2024

Video Series
Video Interviews
Podcasts

Most Recent

© 2024 MJH Life Sciences

All rights reserved.